Mutual Of America Capital Management LLC Arcus Biosciences, Inc. Transaction History

Mutual Of America Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$16.97 - $22.03 $7,721 - $10,023	-455 Reduced 4.24%	10,281 $208,000
Q1 2023 May 04, 2023	SELL	$15.96 - $23.15 $3,048 - $4,421	-191 Reduced 1.75%	10,736 $195,000
Q4 2022 Feb 10, 2023	BUY	$19.7 - $35.71 $11,662 - $21,140	592 Added 5.73%	10,927 $225,000
Q3 2022 Nov 08, 2022	BUY	$23.23 - $30.07 $58,191 - $75,325	2,505 Added 31.99%	10,335 $270,000
Q2 2022 Aug 10, 2022	BUY	$17.23 - $37.73 $134,910 - $295,425	7,830 New	7,830 $198,000

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $950M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.